Patients should not restart tirzepatide and should contact their healthcare team if they experience: inability to keep fluids down for more than 4-6 hours, persistent vomiting for more than 24 hours, severe abdominal pain, or blood glucose levels consistently above 300 mg/dL
Ethics declarations Ethics approval and consent to participate We declare that this manuscript is original, has not been published before, and is not currently being considered for publication elsewhere and that there are no other persons who satisfied the criteria for authorship but are not listed
Most people lose weight with continued treatment after a few months
If Trulicity is appropriate, the clinician issues a valid prescription
Inhibition of food intake in obese subjects by peptide YY336
If cloudiness persists, allow vial to rest for 5-10 minutes and gently swirl again